PATENT CLAIM ANALYSIS

Application Number: 16306361
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "401000"]

Abstract:
There is provided a skin care formulation for transdermal administration of a component of a blood product, the formulation comprising a blood product, a transdermal carrier; and a liposomal base, wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base.

Claim (Index 8):
The formulation of  claim 7  wherein the growth factor is selected from the group consisting of endothelial growth factor (EGF), hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), granulocyte colony-stimulating factor (G-CSF), vascular endothelial growth factor (VEGF), transforming growth factor alpha (TGF-\u03b1), TGF-\u03b21, TGF-\u03b22, TGF-\u03b23, platelet-derived growth factor (PDGF)-AA, PDGF-AB, PDGF-BB, insulin-like growth factor-1 (IGF-1), BMP, BDNF, EGF, HGF,PDGF, FGF, PGF, GDF-8, NGF, Epo, TPO, TCGF, IGF-I, IGF-II, KGF, VEGF, and any combination thereof.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.83333
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13945120', '13041197', '14911215', '14132549', '15147715']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641574482476303
- 35 USC 102 Novelty (BERT): 0.4943449551829894
- Combined Prediction Score: 0.7371761989411663
- Mean Citation Score: 205.539946
- Max Citation Score: 224.02826
- Similarity Product: 155.86712734270571

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test